CC002 (Starg (Wuhan) Pharmaceutical Tech Co Ltd)

N/A

Report date: 2026/01/07 10:16:10
NME

Base Information

Drug NameCC002 (Starg (Wuhan) Pharmaceutical Tech Co Ltd)
Drug Alias NameCC002（楚浦创制）CC-002
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 2 modulators
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesStarg (Wuhan) Pharmaceutical Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesStarg (Wuhan) Pharmaceutical Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A